Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
Sophie Caillat‐Zucman, Romain de Jorna, Caterina Cristinelli, Mark Isabelle et al.
Journal
Bone Marrow Transplantation
Topics
CAR-T cell therapy research
article
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
Sophie Caillat‐Zucman, Romain de Jorna, Caterina Cristinelli, Mark Isabelle, Pierre Stéphan, Miryam Mebarki, Nathalie Parquet, Anne Brignier, Vincent Allain, Di Blasi Roberta, J. Larghero, L. Vercellino, Agathe Vély, Mohamad Sabbah, Mikael Roussel, Ilenia De Bernardis, Pierre Sesques, Amani Ouedrani, Pierre Bories, Rémi Pescarmona, Marta Canelo-Vilaseca, Bommier Côme, Roch Houot, François Vergez, Catherine Thieblemont
article en
Abstract
No abstract available for this paper.
Publication Tag
Bone Marrow Transplantation
Institutions
Université Paris Cité (FR), Centre Hospitalier Universitaire de Toulouse (FR), Université Sorbonne Paris Nord (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Lyon Sud (FR), Hôpital Saint-Louis (FR), Centre Hospitalier Universitaire de Rennes (FR)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma? — Sophie Caillat‐Zucman, Romain de Jorna, et al. · Bone Marrow Transplantation (2026) | TGRS Research Map | TGRS